Breast Cancer Management During the COVID-19 Pandemic: The Senologic International Society Survey.
Fiche publication
Date publication
avril 2021
Journal
European journal of breast health
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MATHELIN Carole, Dr AME Shanti
Tous les auteurs :
Mathelin C, Ame S, Anyanwu S, Avisar E, Boubnider WM, Breitling K, Anie HA, Conceição JC, Dupont V, Elder E, Elfgen C, Elonge T, Iglesias E, Imoto S, Ioannidou-Mouzaka L, Kappos EA, Kaufmann M, Knauer M, Luzuy F, Margaritoni M, Mbodj M, Mundinger A, Orda R, Ostapenko V, Özbaş S, Özmen V, Pagani O, Pieńkowski T, Schneebaum S, Shmalts E, Selim A, Pavel Z, Lodi M, Maghales-Costa M
Lien Pubmed
Résumé
In early 2020, the spread of coronavirus disease-2019 (COVID-19) led the World Health Organization to declare this disease a pandemic. Initial epidemiological data showed that patients with cancer were at high risk of developing severe forms of COVID-19. National scientific societies published recommendations modifying the patients' breast cancer (BC) management to preserve, in theory, quality oncologic care, avoiding the increased risk of contamination. The Senology International Society (SIS) decided to take an inventory of the actions taken worldwide. This study investigates COVID-19-related changes concerning BC management and analyzes the will to maintain them after the pandemic, evaluating their oncological safety consequences.
Mots clés
Breast cancer, COVID-19, SARS-CoV-2, clinical practices, pandemic, survey
Référence
Eur J Breast Health. 2021 Apr;17(2):188-196